rs1024611
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The variant allele was found at a frequency of 0.287 in 152,162 control chromosomes in the GnomAD database, including 6,922 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,risk factor (no stars).
Frequency
Genomes: 𝑓 0.29 ( 6922 hom., cov: 33)
Consequence
Unknown
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.103
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.539 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD3 genomes AF: 0.287 AC: 43582AN: 152044Hom.: 6908 Cov.: 33
GnomAD3 genomes
AF:
AC:
43582
AN:
152044
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.287 AC: 43619AN: 152162Hom.: 6922 Cov.: 33 AF XY: 0.296 AC XY: 21990AN XY: 74382
GnomAD4 genome
AF:
AC:
43619
AN:
152162
Hom.:
Cov.:
33
AF XY:
AC XY:
21990
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1527
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity; risk factor
Submissions summary: Pathogenic:1Benign:1Other:3
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Coronary artery disease, development of, in HIV Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 15, 2009 | - - |
CCL2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 10, 2023 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Mycobacterium tuberculosis, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jan 15, 2009 | - - |
Coronary artery disease, modifier of Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jan 15, 2009 | - - |
Spina bifida, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jan 15, 2009 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at